2025. Development and validation of the competing risk nomogram and risk classification system for predicting cancer-specific mortality in patients with cervical adenosquamous carcinoma treated via radical hysterectomy. Biomolecules and Biomedicine. 25, 5 (Apr. 2025), 1099–1110. DOI:https://doi.org/10.17305/bb.2024.11217.